Up next

Autoplay

Novel Agents and Combinations in Hodgkin Lymphoma

0 Views • 07/09/23
Share
Embed
administrator
administrator
Subscribers
0

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay